| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/01/2011 | US20110212166 Carnitine conjugates of adamantanamines derivatives as dual prodrugs for various uses |
| 09/01/2011 | US20110212164 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 09/01/2011 | US20110212157 Dermal delivery |
| 09/01/2011 | US20110212155 Flexible, Compressed Intravaginal Rings, Methods of Making and Using the Same, and Apparatus for Making the Same |
| 09/01/2011 | US20110212154 Biodegradable Implantable Drug Delivery Device |
| 09/01/2011 | US20110212152 Modified anti-microbial surfaces, devices and methods |
| 09/01/2011 | US20110212150 Process for the treatment of cellulosic molded bones |
| 09/01/2011 | US20110212140 Pressure-sensitive adhesive composition applicable to nail and adhesive agent for nail |
| 09/01/2011 | US20110212133 Novel Methods of Diagnosis and Treatment of P. Aeruginosa Infection and Reagents Therefor |
| 09/01/2011 | US20110212132 Pathogen for bacterial poultry disease |
| 09/01/2011 | US20110212131 Method for enhancing an immune response |
| 09/01/2011 | US20110212130 Live, attenuated respiratory syncytial virus |
| 09/01/2011 | US20110212129 Method for Producing the Flu Virus |
| 09/01/2011 | US20110212128 Universal virus-like particle (VLP) influenza vaccines |
| 09/01/2011 | US20110212126 Inactivated chimeric vaccines and related methods of use |
| 09/01/2011 | US20110212125 Vaccine for shigella |
| 09/01/2011 | US20110212124 Vaccine Composition |
| 09/01/2011 | US20110212123 Immunogenic Substances Comprising a Polyinosinic Acid - Polycytidilic Acid Based Adjuvant |
| 09/01/2011 | US20110212121 Recombinant chimeric antigens for diagnosis and prevention of scrub typhus |
| 09/01/2011 | US20110212120 Ykur polynucleotides and polypeptides |
| 09/01/2011 | US20110212119 Methods for making hiv vaccines and related compositions |
| 09/01/2011 | US20110212118 TAT Protein for preventing or treating AIDS |
| 09/01/2011 | US20110212117 Influenza hemagglutinin and neuraminidase variants |
| 09/01/2011 | US20110212114 Method for making targeted therapeutic agents |
| 09/01/2011 | US20110212111 MHC II Associated Protein and Uses Thereof |
| 09/01/2011 | US20110212106 Hiv-1 neutralizing antibodies and uses thereof |
| 09/01/2011 | US20110212103 Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions |
| 09/01/2011 | US20110212100 Methods for modulating development and expansion of il-17 expressing cells |
| 09/01/2011 | US20110212094 Dual variable domain immunoglobulins and uses thereof |
| 09/01/2011 | US20110212090 Combinatorial Analysis and Repair |
| 09/01/2011 | US20110212082 Method for producing tablet comprising natural allicin |
| 09/01/2011 | US20110212080 Urea derivatives as antibacterial agents |
| 09/01/2011 | US20110212079 Adaptive biochemical signatures |
| 09/01/2011 | US20110212078 Synthesis and use of heterocyclic antibacterial agents |
| 09/01/2011 | US20110212076 Viral Therapeutic |
| 09/01/2011 | US20110212073 Purine nucleoside phosphorylase as enzymatic activator of nucleoside prodrugs |
| 09/01/2011 | US20110212071 Anti third party central memory t cells, methods of producing same and use of same in transplantation and disease treatment |
| 09/01/2011 | US20110212057 Cycloundecadepsipeptide compounds and use of said compounds as a medicament |
| 09/01/2011 | US20110212056 Combination therapy for the treatment of liver diseases |
| 09/01/2011 | US20110212051 Variants of vascular endothelial growth factor (vegf) receptor and use thereof |
| 09/01/2011 | US20110212028 Chemically modified cell-penetrating peptides for improved delivery of gene modulating compounds |
| 09/01/2011 | CA2828114A1 Cephalosporin derivatives useful as .beta.-lactamase inhibitors and compositions and methods of use thereof |
| 09/01/2011 | CA2791190A1 Ophthalmic solution for treating ocular infection comprising levofloxacin or salt thereof or solvate of the same, method for treating ocular infection, levofloxacin or salt thereof or solvate of the same, and use thereof |
| 09/01/2011 | CA2791025A1 Method of inducing the production of protective anti-hiv-1 antibodies |
| 09/01/2011 | CA2790984A1 Combination vaccine for streptococcus |
| 09/01/2011 | CA2790922A1 Method for preparing regulatory dentritic cells |
| 09/01/2011 | CA2789457A1 1,3,4,8-tetrahydro-2h-pyrido[1,2-a]pyrazine derivative and use of same as hiv integrase inhibitor |
| 09/01/2011 | CA2789140A1 Synthesis of magnolol and its analogue compounds |
| 08/31/2011 | EP2362221A1 Antagonists of HMG1 for treating inflamatory conditions |
| 08/31/2011 | EP2361981A1 RNA sequence-specific mediators of RNA interference |
| 08/31/2011 | EP2361930A2 Multimers of MHC-peptide complexes and uses thereof in Borrelia infectious diseases |
| 08/31/2011 | EP2361922A1 Intermediate to HCV-Nucleoside Inhibitors |
| 08/31/2011 | EP2361921A2 Novel bicyclonucleoside and oligonnucleotide analogue |
| 08/31/2011 | EP2361920A2 Preparation and use of carbohydrate-based ring structures with antimicrobial and cytostatic activity |
| 08/31/2011 | EP2361913A1 Anti-infective agents |
| 08/31/2011 | EP2361622A1 Use of lipoxin analogs to promote cell defense against gram-negative infections |
| 08/31/2011 | EP2361249A2 System and method for controlling growth of microganisms with brominated furanones |
| 08/31/2011 | EP2361084A2 Electrostatically charged multi-acting nasal application, product, and method |
| 08/31/2011 | EP2187915B1 Use of the peptide phpfhlfvy (renin inhibitor) in anti-angiogenic therapy of certain diseases |
| 08/31/2011 | EP2121697B1 Compounds for the treatment of hepatitis c |
| 08/31/2011 | EP2073810B1 Use of 2-6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethyl-4-fluoro-benzonitrile for treating diabetes, cancer, autoimmune disorders and hiv infection |
| 08/31/2011 | EP2054431B1 Conformers of bacterial adhesins |
| 08/31/2011 | EP2031057B1 SENSE OLIGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME |
| 08/31/2011 | EP1634589B9 Aqueous olanexidine solution, method of preparing the same, and disinfectant |
| 08/31/2011 | EP1523320B1 Megasphaera elsdenii strain and its uses |
| 08/31/2011 | EP1521754B1 Viral inhibitors |
| 08/31/2011 | EP1506000B9 Heterocyclicsulfonamide hepatitis c virus inhibitors |
| 08/31/2011 | EP1446422B1 Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation method and immunogenic compositions comprising same |
| 08/31/2011 | EP1402015B1 A soluble complex comprising a retroviral surface glycoprotein and fkpa or slyd |
| 08/31/2011 | EP1361869B1 Transdermal therapeutic system containing testosterone and method for the production thereof |
| 08/31/2011 | EP1109562B1 Composite biocidal particles |
| 08/31/2011 | CN1813984B Chinese medicine preparation for treating liver disease and preparing method |
| 08/31/2011 | CN1813683B Azithromycin for suspension and its preparing method |
| 08/31/2011 | CN102171334A Method for producing purified influenza virus antigen |
| 08/31/2011 | CN102171249A Long-acting interferons and derivatives thereof and methods thereof |
| 08/31/2011 | CN102171240A Methods of treating inflammation |
| 08/31/2011 | CN102171185A Methionine analogs and methods of using same |
| 08/31/2011 | CN102170908A Delivery of a CD40 agonist to a tumor draining lymph node of a subject |
| 08/31/2011 | CN102170904A Composition comprising chitosan for ocular administration of vaccine(s) to avians |
| 08/31/2011 | CN102170902A Influenza vaccines |
| 08/31/2011 | CN102170890A Anti-avian influenza virus agent, and product containing anti-avian influenza virus agent |
| 08/31/2011 | CN102168088A T cell immunogen gene TI and applications thereof in foot-and-mouth disease protein subunit vaccine and inactivated vaccine |
| 08/31/2011 | CN102168073A Method for improving proliferation capability of mycoplasma gallisepticum in vaccine production |
| 08/31/2011 | CN102168068A Method for amplifying V alpha24NKT (Natural Killer T) cells from peripheral blood |
| 08/31/2011 | CN102167736A Green mud crab antibacterial peptide Sphistin and application thereof |
| 08/31/2011 | CN102167734A High-efficiency expression and application of recombinant mutant tenebrio molitor antibacterial peptide |
| 08/31/2011 | CN102166362A Porcine reproductive and respiratory syndrome live vaccine heat-resistant freeze-drying protective agent and preparation method thereof |
| 08/31/2011 | CN102166356A Application of alpha-mannatide as vaccine adjuvant and vaccine preparation prepared using same |
| 08/31/2011 | CN102166355A Quadruple inactivated vaccine for preventing chicken diseases |
| 08/31/2011 | CN102166354A Rabies inactivated vaccine and preparation method thereof |
| 08/31/2011 | CN102166353A A spray for treating diseases caused by human papilloma viruses and a preparation method |
| 08/31/2011 | CN102166352A Preparation method of swine influenza bivalent inactivated vaccine and product of swine influenza bivalent inactivated vaccine |
| 08/31/2011 | CN102166351A H1N1 influenza A vaccine and application thereof |
| 08/31/2011 | CN102166350A Flounders quintuplet inactivated vaccine and preparation method thereof |
| 08/31/2011 | CN102166329A Medicine for treating leukopenia caused by chronic hepatitis B or interferon and preparation method thereof |
| 08/31/2011 | CN102166313A Medicine for curing tinea pedis |
| 08/31/2011 | CN102166304A Compound Chinese medicine for treating multidrug-resistant tuberculosis |
| 08/31/2011 | CN102166285A Umbilical plaster for treating allergic skin itching and psoriasis and preparation method thereof |
| 08/31/2011 | CN102166280A Chinese medicinal composition for preventing and treating common cold and influenza and preparation method thereof |
| 08/31/2011 | CN102166276A Traditional Chinese medicine composition for preventing and treating influenza A and preparation method and application thereof |